BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30129658)

  • 21. Overexpression of c-Met promotes invasion and metastasis of small oral tongue carcinoma.
    Lim YC; Han JH; Kang HJ; Kim YS; Lee BH; Choi EC; Kim CH
    Oral Oncol; 2012 Nov; 48(11):1114-9. PubMed ID: 22704061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased expression of Beclin‑1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma.
    Hu Z; Zhong Z; Huang S; Wen H; Chen X; Chu H; Li Q; Sun C
    Mol Med Rep; 2016 Aug; 14(2):1567-73. PubMed ID: 27356955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.
    Heaton CM; Durr ML; Tetsu O; van Zante A; Wang SJ
    Laryngoscope; 2014 Jul; 124(7):E267-73. PubMed ID: 24431303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma.
    Endo K; Shirai A; Furukawa M; Yoshizaki T
    Hum Pathol; 2006 Aug; 37(8):1111-6. PubMed ID: 16867875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of FGF-2/FGFR-1 in normal mucosa, salivary gland, preneoplastic, and neoplastic lesions of the oral cavity.
    Mariz BALA; Soares CD; Morais TML; Fonseca FP; de Carvalho MGF; Jorge J
    J Oral Pathol Med; 2018 Oct; 47(9):816-822. PubMed ID: 30080932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma.
    Åström P; Juurikka K; Hadler-Olsen ES; Svineng G; Cervigne NK; Coletta RD; Risteli J; Kauppila JH; Skarp S; Kuttner S; Oteiza A; Sutinen M; Salo T
    Br J Cancer; 2017 Sep; 117(7):1007-1016. PubMed ID: 28772283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metallothionein expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patient survival.
    Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Sastre-Garau X
    Histopathology; 2011 Sep; 59(3):514-25. PubMed ID: 22034891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical study of overexpression of fibroblast growth factor-1 (FGF-1), FGF-2, and FGF receptor-1 in human malignant salivary gland tumours.
    Myoken Y; Myoken Y; Okamoto T; Sato JD; Kan M; McKeehan WL; Nakahara M; Takada K
    J Pathol; 1996 Apr; 178(4):429-36. PubMed ID: 8691322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival in patients under 45 years with squamous cell carcinoma of the oral tongue.
    Manuel S; Raghavan SK; Pandey M; Sebastian P
    Int J Oral Maxillofac Surg; 2003 Apr; 32(2):167-73. PubMed ID: 12729777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significant effects of lymph and blood vascular invasion on the prognosis of early-stage cervical squamous cell carcinoma.
    Zhang Y; Yan M; He J; Sun J; Sun X
    J Obstet Gynaecol Res; 2010 Oct; 36(5):1015-22. PubMed ID: 20846259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simple novel prognostic model for early stage oral tongue cancer.
    Almangush A; Coletta RD; Bello IO; Bitu C; Keski-Säntti H; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Tommola S; Soini Y; Kosma VM; Koivunen P; Kowalski LP; Nieminen P; Grénman R; Leivo I; Salo T
    Int J Oral Maxillofac Surg; 2015 Feb; 44(2):143-50. PubMed ID: 25457829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toll-like receptors 2, 4, and 9 in primary, metastasized, and recurrent oral tongue squamous cell carcinomas.
    Mäkinen LK; Ahmed A; Hagström J; Lehtonen S; Mäkitie AA; Salo T; Haglund C; Atula T
    J Oral Pathol Med; 2016 May; 45(5):338-45. PubMed ID: 26426362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral tongue squamous cell carcinoma in never-smokers: analysis of clinicopathologic characteristics and survival.
    Durr ML; van Zante A; Li D; Kezirian EJ; Wang SJ
    Otolaryngol Head Neck Surg; 2013 Jul; 149(1):89-96. PubMed ID: 23533221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of the fibroblast growth factor receptor-1 gene correlates with liver metastasis in colorectal cancer.
    Sato T; Oshima T; Yoshihara K; Yamamoto N; Yamada R; Nagano Y; Fujii S; Kunisaki C; Shiozawa M; Akaike M; Rino Y; Tanaka K; Masuda M; Imada T
    Oncol Rep; 2009 Jan; 21(1):211-6. PubMed ID: 19082464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between vascular endothelial growth factor and Notch1 expression and lymphatic metastasis in tongue cancer.
    Joo YH; Jung CK; Kim MS; Sun DI
    Otolaryngol Head Neck Surg; 2009 Apr; 140(4):512-8. PubMed ID: 19328339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma.
    Xie N; Wang C; Liu X; Li R; Hou J; Chen X; Huang H
    J Oral Pathol Med; 2015 Apr; 44(4):266-72. PubMed ID: 25169851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRB3 overexpression due to endoplasmic reticulum stress inhibits AKT kinase activation of tongue squamous cell carcinoma.
    Zhang J; Wen HJ; Guo ZM; Zeng MS; Li MZ; Jiang YE; He XG; Sun CZ
    Oral Oncol; 2011 Oct; 47(10):934-9. PubMed ID: 21821462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors and outcomes for salvage surgery in patients with recurrent squamous cell carcinoma of the tongue.
    Goto M; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Hyodo I; Kodaira T; Ogawa T; Fujimoto Y; Terada A; Kato H; Hasegawa Y
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e141-8. PubMed ID: 23909955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
    Kono M; Watanabe M; Abukawa H; Hasegawa O; Satomi T; Chikazu D
    J Oral Maxillofac Surg; 2013 Oct; 71(10):1694-702. PubMed ID: 23809761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basic fibroblast growth factor receptors and their prognostic value in human breast cancer.
    Blanckaert VD; Hebbar M; Louchez MM; Vilain MO; Schelling ME; Peyrat JP
    Clin Cancer Res; 1998 Dec; 4(12):2939-47. PubMed ID: 9865904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.